FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.38), $0.21 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $24.3 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.